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Summary 
 
 
Between January 2005 and December 2005, 199 meticillin-resistant Staphylococcus 
aureus (MRSA) isolates were obtained from non-hospitalized patients presenting skin 
and soft tissue infections to local general practitioners. The study area incorporated 57 
surgeries from three Primary Care Trusts in the Lichfield, Tamworth, Burntwood, 
North and East Birmingham regions of Central England, UK. Following antibiotic 
sensitivity testing, pulsed-field gel electrophoresis, Panton-Valentine leukocidin gene 
detection and SCCmec element assignment, 95% of the isolate population were 
determined genetically related to hospital epidemic strains EMRSA-15 and EMRSA-
16. In total 87% of the isolate population harboured SCCmec IV, 9% SCCmec II and 
4% were identified to carry novel SCCmec IIIa-mecI. When mapped to patient home 
postcode a diverse distribution of isolates harbouring SCCmec II and SCCmec IV was 
observed, however the majority of isolates harbouring SCCmec IIIa-mecI were isolated 
from patients residing in the north-west of the study region highlighting a possible 
localized clonal group. Evidential transmission of MRSA from the hospital setting 
into the surrounding community population, as demonstrated by this study, warrants 
the need for targeted patient screening and de-colonisation in both the clinical and 
community environment.   
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Introduction 
 
 
Meticillin-resistant Staphylococcus aureus and its association with UK hospital-
acquired infections has been well documented.1-4 However, following four pediatric 
deaths in Dakota and Minnesota,5 the emergence of MRSA in the community setting 
has become a major focal point of epidemiological research.6-11 Meticillin-resistant 
Staphylococcus aureus clones of true community origin arise from the horizontal 
transfer of mecA into circulating meticillin-sensitive Staphylococcus aureus strains 
and are typically characterized by the presence of SCCmec IV, susceptibility to non-ß-
lactams and the gene locus for Panton-Valentine leukocidin (PVL).6, 12-13 
Predominantly associated with invasive soft-tissue infections, community-derived 
MRSA strains are evidently a worldwide concern.8 However, increasing evidence for 
the dissemination of hospital epidemic strains into the community population indicate 
that the lines defining hospital- and community- MRSA acquisition are becoming 
increasingly difficult to define.14-15 In the UK the prevalence of true  
community-acquired MRSA (CA-MRSA) remains low. However, the detection of pvl 
genes in strains related to EMRSA-15 and 16 clones 16 and the report of pvl-positive 
CA-MRSA in the West Midlands 17 warrants continued surveillance for emerging 
virulent clones within the UK clinical and community population. The aim of this 
study was to characterize the epidemiology of MRSA strains circulating within the 
Central England community encompassing the regions of Lichfield, Tamworth, 
Burntwood, North and East Birmingham. 
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Methods 
 
 
Bacterial isolates 
 
 
Between January 2005 and December 2005, 199 MRSA isolates were obtained from 
non-hospitalized patients presenting skin and soft tissue infections to local general 
practitioners. The study area incorporated 57 surgeries from three Primary Care Trusts 
in the Lichfield, Tamworth, Burntwood, North and East Birmingham regions of 
Central England, UK. Prior in-patient or out-patient hospital history was determined 
from the Good Hope Hospital information system (dating back to 1994).  Patient GP 
records were consulted in those cases where hospital records were not available. 
Permission to undertake this study was granted by the Medical Director of Good Hope 
Hospital NHS Trust and the Director of Public Health of North Birmingham Primary 
Care Trust. Formal ethical approval was not required as patient identifiers, such as 
name and NHS registration number, were deleted from the datasets.  
 
 
Antibiotic sensitivity testing 
 
 
Isolate identification was undertaken at the Good Hope Hospital NHS Trust, Sutton 
Coldfield, following standard laboratory procedures. For all presumptive MRSA, 
sensitivity to erythromycin, trimethoprim, rifampicin, gentamicin, tetracycline, 
mupirocin, vancomycin, fusidic acid and meticillin was determined using the British 
Society for Antimicrobial Chemotherapy (BSAC) disc diffusion method.18 
 
 
Molecular characterization of MRSA 
 
 
Rapid DNA extraction by boiling 
 
 
For all PCR protocols employed, chromosomal DNA was extracted by a rapid boil 
extraction method.19    
 
 
Multiplex PCR for SCCmec element assignment 
 
 
Staphylococcal Cassette Chromosome mec (SCCmec) element assignment and 
Panton-Valentine leukocidin gene locus detection were determined for all MRSA 
isolates using primers and cycle conditions obtained from previously described 
methods.6, 20 All PCR protocols were undertaken using Gene Amp PCR system 9700 
(Applied Biosystems, UK). In addition, SCCmec types were mapped to the centroids 
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of the full UK unit postcodes (each UK postcode is shared by 15-20 households) 
determined by the UK National Statistics Postcode Directory.  
 
 
Pulsed-field gel electrophoresis 
 
 
Pulsed-field gel electrophoresis was performed on all MRSA isolates using previously 
published protocols.21-22 Staphylococcus aureus NCTC 8325 was used as a control 
and molecular weight marker. 
 
 
Results 
 
 
Patient demographics 
 
 
Within the population of this study, 33 (17%) patients were recorded to be in long 
term nursing care facilities and 166 (83%) lived at home.  Additionally, 148 (74%) 
patients were 65 years old and above and 51 (26%) were below the age of 65.  In 
total, 38% of the patient study set had no recorded inpatient or outpatient hospital 
visit. 
 
 
Antibiotic sensitivity testing  
 
 
Seven MRSA isolates exhibited resistance to six or more antibiotics, five of which 
harboured SCCmec II and two SCCmec IV. Isolates with resistance to six or more 
antibiotics were designated multi-drug resistant (MR-MRSA). Thirty-seven MRSA 
isolates were resistant to meticillin alone, 36 of which harboured SCCmec IV and one 
harboured SCCmec II. The remaining 155 isolates exhibited resistance to at least one 
non-ß-lactam (Table I). 
 
 
Multiplex PCR for SCCmec element assignment 
 
 
Following SCCmec element assignment, 173 (87%) of the MRSA isolate population 
harboured SCCmec IV, 18 (9%) harboured SCCmec II and eight (4%) were identified 
to carry a novel variant designated SCCmec IIIa-mecI. Variant SCCmec IIIa-mecI was 
characterized by the amplification of the loci specific to SCCmec IIIa but minus the 
209bp amplification product internal to mecI.20 Mapping SCCmec type to patient 
home postcode demonstrated a diverse distribution of isolates harbouring SCCmec II 
and SCCmec IV. Seven of the eight isolates harbouring SCCmec IIIa-mecI appeared to 
be localized in the north-west of the study region (figure 1).   
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Pulsed-field gel electrophoresis analysis 
 
 
Pulsed-field gel electrophoresis analysis of the 199 MRSA isolates identified five 
distinct PFGE profile groups designated A1, B1, C1, D1 and E1. Profile A1 was 
identified in 21% of the isolate population and represented a typical EMRSA-15 
progenitor profile.23 Following Tenover criteria,21 20 closely related subtypes were 
designated to profile A1 (A2-A21) and all isolates belonging to this group were 
identified to carry SCCmec IV. In total 173 isolates were genetically related subtypes 
of EMRSA-15 accounting for 87% of the isolate population. PFGE profile B1 was 
identified in 2% of the isolate population and represented a typical EMRSA-16 
progenitor profile.24 Five closely related subtypes were designated to profile B1 (B2-
B6) and all isolates belonging to this group were identified to carry SCCmec II. In 
total 16 isolates were genetically related subtypes of EMRSA-16 accounting for 8% 
of the isolate population. Two SCCmec II isolates were characterized to PFGE 
profiles C1 and D1 and were not related to EMRSA-16 by Tenover criteria. One 
closely related subtype was designated to profile E1 (E2) and all eight isolates 
belonging to this group were identified to carry SCCmec IIIa-mecI.   
 
 
Pvl gene locus detection 
 
 
The pvl gene locus was not detected in any of the 199 MRSA isolates analysed in this 
investigation. 
 
 
Discussion 
 
 
Following PFGE analysis, 95% of the isolates retrieved from the Lichfield, 
Tamworth, Burntwood, North and East Birmingham community, were representative 
of hospital acquired EMRSA-15 or EMRSA-16 genetic lineage.23-24 In addition 81% 
of the isolate population displayed resistance to at least one non-ß-lactam and the gene 
locus for Panton-Valentine leukocidin was not detected in any of the 199 MRSA 
isolates, further exemplifying the probable acquisition of these strains from a clinical 
setting.25-26 In contrast, within the USA, community acquired-MRSA (USA 300) has 
become a significant strain both in the community and hospital environment.27 
Following phenotypic and genotypic analysis, all MRSA isolates retrieved from the 
West Midlands community in this study were not characteristic of CA-MRSA, further 
highlighting MRSA isolates from the UK community predominantly represent a 
spillover of epidemic MRSA strains from the hospital setting.28 This observed 
epidemiological pattern is similar to that reported in West Midlands based hospital 
studies where the predominant strains also relate to EMRSA-15 and EMRSA-16 
PFGE profiles.19 
 
  
Patients predisposed to MRSA may remain undetected if symptoms fail to present 
whilst undergoing hospital treatment.  The subsequent discharge of carrier patients 
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may provide an ideal mechanism for transmission of nosocomial derived strains 
within the community population.29 Additionally, re-admittance of such carrier 
patients may further impact upon current hospital MRSA rates.30-31 It is interesting to 
note that 17% of the patient population were resident in a nursing care facility and 
74% were above the age of 65.  Such patients are typically associated with higher 
rates of MRSA carriage,32-33 however, 38% of the patient study set had no recorded 
inpatient or outpatient hospital visit.  As 96% of isolates from these patients were 
genetically related to EMRSA 15 or 16, this observation may further reflect the spread 
of nosocomial MRSA within the community setting from those patients susceptible to 
MRSA carriage to individuals without recent recorded hospital contact. With this in 
mind, hospital infection control measures should therefore act upon reducing the 
reservoir of hospital-associated MRSA in the general population.  Such action should 
take into account the discharge of symptomatic and asymptomatic MRSA positive 
patients and the implementation of targeted screening in patients with associated risk 
factors for acquisition (in particular the elderly).14, 29, 32 It should, however, be 
recognized that it was not possible to estimate the exposure of these patients to other 
hospital settings with the information available in this study. 
 
 
Previous studies have associated SCCmec IV with increased fitness and 
transmissibility.34-35 It should therefore be noted that 87% of the MRSA isolate 
population harboured SCCmec IV, providing further evidence for the importance of 
this genetic element in MRSA transmission outside of the nosocomial setting. 
 
 
Molecular analysis of novel SCCmec IIIa-mecI  
 
 
From the map produced in figure 1, a diverse distribution of SCCmec II and SCCmec 
IV was observed.  In contrast, seven of the eight isolates harbouring SCCmec IIIa-mecI 
appeared to be localized in the north-west of the study region. Following PFGE 
analysis, isolates harbouring SCCmec IIIa-mecI produced banding profiles that were 
95% related and genetically distinct from the remaining isolate population.  This may 
possibly signify a population of minor sporadic clones,36 unfortunately ethical 
considerations prevented detailed investigation into patient demographics which may 
have provided scope for further analysis of the SCCmec IIIa-mecI cluster. Novel 
SCCmec elements are reportably widespread 20, 37 however,  identification of  SCCmec 
IIIa-mecI  was not unique to this study setting.38 The continued evolution of novel 
structural variants currently complicates the accurate identification of SCCmec and 
the future development of a robust typing protocol is currently required.39-42  
 
 
In conclusion, following phenotypic and genotypic analysis, all MRSA isolates 
retrieved from the West Midlands community were not characteristic of  
CA-MRSA. The majority of the isolate population was identified to be related to 
hospital epidemic strains, demonstrating the probable transmission of MRSA from the 
hospital setting into the surrounding community population. The predominance of 
MRSA isolates harboring SCCmec IV demonstrates the transmissible success of 
SCCmec IV to prevail outside of the hospital setting. Furthermore the identification of 
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novel SCCmec types reveals the genetic plasticity of the SCCmec structure and the 
potential for emerging minor sporadic clones. The UK Department of Health has 
committed itself to comprehensive hospital based MRSA screening; however this 
strategy does not take into account the possibility of MRSA transmission within the 
community setting.  The migration of hospital acquired MRSA strains into the 
community environment raises questions about the best way to control the organism, 
but these questions are beyond the scope of this paper. However, this study has shown 
that detailed molecular investigation is feasible and advantageous in understanding 
MRSA in the community. Similar studies, coupled with more detailed patient data, 
could be valuable in the assessment of hospital-based or community-based 
interventions designed to control MRSA. 
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Legends 
 
 
Table I. 
Antibiotic resistance phenotypes and SCCmec types of 199 MRSA isolates 
obtained from the Lichfield, Tamworth, Burntwood, North and East 
Birmingham community. 
 
Figure 1.  
SCCmec types mapped to patient home postcode for 199 MRSA isolates obtained 
from the Lichfield, Tamworth, Burntwood, North and East Birmingham 
community. 
 
